Research Article
Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients
Table 10
Baseline characteristics weighted by the inverse propensity score.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note: observations are weighted by inverse propensity scores calculated from multinomial logistic regressions with regressors including demographic factors such as age and sex, socioeconomic factors such as education, household income, type of medical insurance, and city of residence, diabetes-related morbidities such as AMI, hypertension, dyslipidemia, and stroke, duration of diabetes, behavior factors such as alcohol use, smoking, physical exercise, and diet control, anthropometric and physiological indicators such as BMI, blood glucose level, HbA1c, blood pressure, TCH, TG, and HRQoL measured as EQ-5D score. The last column includes significant levels derived from ANOVA tests regarding the variable difference between treatment plans. |